ACE inhibitors and target organ protection

An expanded role for these antihypertensive agents?

Robert D. Toto Dr Toto is professor of internal medicine-nephrology, Southwestern Medical School, University of TexasSouthwestern Medical Center at Dallas

, MD,

Steven Rinner Dr Rinner is senior member of Dallas Nephrology Associates and clinical assistant professor of medicine, Southwestern Medical School

, MD &

C. Venkata S. Ram Dr Ram is a member of Dallas Nephrology Associates, medical director, Texas Blood Pressure Institute, Dallas, and clinical professor of medicine, Southwestern Medical School.

, MD

PREVIEW

Lowering the risk of cardiovascular disease (CVD) involves more than treatment of individual risk factors such as hypertension, diabetes, and chronic kidney disease. In this article, Drs Toto, Rinner, and Ram present an evidence-based approach to reducing CVD risk and suggest that optimal treatment with angiotensin-converting enzyme (ACE) inhibitors should be extended to a larger proportion of at-risk patients and in particular to those not previously considered candidates for use of these agents.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

ACE inhibitors and target organ protection

An expanded role for these antihypertensive agents?

Information for

Open access

Opportunities

Help and information

ACE inhibitors and target organ protection

An expanded role for these antihypertensive agents?

PREVIEW

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature